SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-21-015143
Filing Date
2021-11-09
Accepted
2021-11-09 06:29:49
Documents
3
Period of Report
2021-11-09

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20211109x6k.htm 6-K 17819
2 EX-99.1 tmb-20211109xex99d1.htm EX-99.1 101264
3 GRAPHIC tmb-20211109xex99d1001.jpg GRAPHIC 4212
  Complete submission text file 0001558370-21-015143.txt   126026
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39950 | Film No.: 211389773
SIC: 2836 Biological Products, (No Diagnostic Substances)